Latest Headlines
-
AST To Exhibit Aseptic Filling Technologies At Advanced Therapies Week
12/27/2023
AST has over 50 years of experience designing, manufacturing, and servicing innovative, high quality and highly automated processing equipment. Beginning in 2006, AST leveraged our experience and close customer relationships to revolutionize the aseptic fill/finish industry with the launch of the ASEPTiCell® development.
- We Are Becoming Cencora PharmaLex 12/27/2023
-
AST Offers Aseptic Processing Solutions For Life Science Innovators
12/22/2023
The path to a successful life science startup is exciting, difficult, and unpredictable. Recent years have seen a volatile pattern emerge of challenge, change and innovation within the life sciences.
-
An As-Needed Approach To Aseptic Pharmaceutical Fill-Finish Change Parts
12/13/2023
Aseptic fill-finish professionals are continually looking to augment their approach to a market that continues to grow and reflect innovations happening around sterile parenteral treatments.
- CleanSpace Accelerates Cleanroom Design-Build Process For Life Science Manufacturers By Connecting Cleanrooms To Real Estate 11/30/2023
-
Refeyn's New KaritroMP Quickly Analyzes Large Viral Vectors
11/30/2023
New macro mass photometer can assess the stability, quality, and purity of adenovirus and lentivirus vectors within just minutes.
-
CPC Celebrates 10th Anniversary Of AseptiQuik® G Connectors
11/15/2023
Single-use technologies (SUT) have radically changed biopharmaceutical operations. Sterile single-use connectors are key to enabling this shift. CPC, the leader in the design and manufacture of single-use connection technologies for life sciences markets, introduced its genderless single-use AseptiQuik® G Connectors 10 years ago and continues to expand its aseptic connector portfolio.
-
Cytiva And RoosterBio Collaborate To Address Exosome Manufacturing Challenges
10/31/2023
Biotechnology leaders Cytiva and RoosterBio, Inc., are teaming up to develop a purification process to manufacture exosomes in mass quantities. This collaboration brings together the strengths of both companies to solve one of the biggest challenges currently limiting the use of exosomes as therapeutics and as delivery vehicles for gene therapies and other biologics.
-
Germfree Laboratories And Title21 Health Solutions Transform Cell And Gene Therapy Manufacturing With Decentralized Innovation
10/24/2023
Germfree Laboratories and Title21 Health Solutions team up to revolutionize healthcare manufacturing, putting patient access at the forefront through decentralized innovation.
-
NYBC Enterprises Acquires Commercial-Scale CGT Facilities
10/18/2023
This acquisition expands Comprehensive Cell Solutions, a business unit of NYBCe, capabilities and geographic reach as a commercial-scale cell therapy clinical development and manufacturing organization.